[Cardiological treatment and pregnancy].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004554:Electric Countershock; D005112:Extracorporeal Circulation; D005260:Female; D005313:Fetal Death; D005602:France; D005865:Gestational Age; D006330:Heart Defects, Congenital / Q000628:therapy; D006801:Humans; D008428:Maternal Mortality; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D011802:Quinidine / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D000959:Antihypertensive Agents; D004071:Digitalis Glycosides; D004232:Diuretics; D011802:Quinidine
Thérapeutique cardiologique et grossesse